The Rise of mRNA Technology In Parenteral Drug Manufacturing

The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production method, which maintains minimal inventory to match customer demand efficiently. An issue that emerged in parenteral […]

CPHI Milan Returns To Fiera Milano And The Lombardy Pharma Region For 2024

CPHI , the world’s largest pharmaceutical event – spanning the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging – returns to Fiera Milano (Rho) in 2024, October 8-10. The global pharma exhibition, organised by Informa, will be hosted in the city of Milan for the second time in three years […]

Lonza Launches Nebula Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing

Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing. Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte lysate (TAL) assays to assure the safety of raw materials in-process samples and manufactured products. […]

The Adderall Shortage: FDA & DEA Seek Increased Production

The FDA and DEA are urging drug manufacturers to ramp up production of prescription stimulants, such as Adderall, due to the ongoing shortage that has lasted almost a year. They indicated in a joint letter that they are working with suppliers, manufacturers, and other interested parties to solve the present shortfall and take precautions against […]

Green Shift In The Pharmaceutical Industry Through PPWR

The global push towards sustainability is undeniable and is becoming increasingly evident in various aspects of our daily lives, from the vehicles we use to the food we consume. While patient well-being remains the top priority for the pharmaceutical industry, now is the opportune moment for pharmaceutical companies to recognize the significance of environmental health. […]

AI, Automation, And More Reshaping Pharmaceutical Packaging

In the upcoming years of 2023 and beyond, various factors will significantly influence drug development and its associated packaging requirements. These factors include advancements in AI for pharmaceutical manufacturing, the demand for novel injectable dosage forms, and a heightened emphasis on sustainability. These trends will bring about substantial changes to the pharmaceutical sector over the […]

Circular Healthcare Plastics Approaches For Greener Future

The topic of sustainability in healthcare and medical device packaging involves numerous factors, such as the necessity for sterilized items, specialized waste management, and strict regulations. However, within this intricate landscape, several efforts are being undertaken to enhance the circularity of healthcare plastics. These initiatives encompass packaging design, material reevaluation, inventive recovery methods, and emerging […]

Parexel, Partex Partner to Accelerate Drug Discovery and Development

Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for biopharmaceutical customers, and to de-risk portfolio assets. Parexel’s extensive global expertise across Phase I to IV […]

AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement

AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site. AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to perform process transfer, process optimization, and clinical manufacturing of the Asahi Kasei Pharma drug substance. […]

Chiesi, Aliada Therapeutics Enter Drug Delivery Alliance

Chiesi Global Rare Diseases has entered a co-development agreement with Aliada Therapeutics, a biotechnology company developing a novel blood-brain barrier (BBB)-crossing platform technology to address challenging disease areas with high unmet need. The collaboration will focus on multiple enzyme cargoes modified with Aliada’s Modular Delivery (MODEL) platform, which harnesses endogenous brain endothelial cell transport mechanisms […]